申请人:——
公开号:US20010053776A1
公开(公告)日:2001-12-20
9-(4-Methylthiazol-2-yl)- 11-(pyridin-4-yl)-6,7-dihydro-5H-2, 7a-diazadibenzo[a,c]cyclohepten-8-one, and pharmaceutically acceptable salts thereof, are selective ligands for GABAA receptors, in particular having high affinity for the a2 and/or a3 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of disorders of the central nervous system, including anxiety and convulsions.
9-(4-甲基噻唑-2-基)-11-(吡啶-4-基)-6,7-二氢-5H-2,7a-二氮杂二苯并[a,c]环庚-8-酮及其药学上可接受的盐是GABA A 受体的选择性配体,特别是对其中的a2和/或a3亚单位具有高亲和力,因此对于治疗和/或预防中枢神经系统疾病,包括焦虑和惊厥,具有益处。